特应性皮炎
皮肤屏障
钥匙(锁)
免疫学
受体
杜皮鲁玛
医学
生物
皮肤病科
内科学
生态学
作者
Almog Bitton,Shmuel Avlas,Hadar Reichman,Michal Itan,Danielle Karo‐Atar,Nurit Pereg Azouz,Perri Rozenberg,Yael Diesendruck,Limor Nahary,Marc E. Rothenberg,Itai Benhar,Ariel Munitz
出处
期刊:Science immunology
[American Association for the Advancement of Science]
日期:2020-02-14
卷期号:5 (44)
被引量:87
标识
DOI:10.1126/sciimmunol.aaw2938
摘要
mice, which lack the type 2 IL-4R, revealed that dermatitis, including ear and epidermal thickening, was dependent on type 2 IL-4R signaling. Expression of TNF-α was dependent on the type 2 IL-4R, whereas induction of IL-4, IgE, CCL24, and skin eosinophilia was dependent on the type 1 IL-4R. Neutralization of IL-4, IL-13, and TNF-α as well as studies in bone marrow-chimeric mice revealed that dermatitis, TNF-α, CXCL1, and CCL11 expression were exclusively mediated by IL-13 signaling via the type 2 IL-4R expressed by nonhematopoietic cells. Conversely, induction of IL-4, CCL24, and eosinophilia was dependent on IL-4 signaling via the type 1 IL-4R expressed by hematopoietic cells. Last, we pharmacologically targeted IL-13Rα1 and established a proof of concept for therapeutic targeting of this pathway in AD. Our data provide mechanistic insight into the differential roles of IL-4, IL-13, and their receptor components in allergic skin and highlight type 2 IL-4R as a potential therapeutic target in AD and other allergic diseases such as asthma and eosinophilic esophagitis.
科研通智能强力驱动
Strongly Powered by AbleSci AI